Table 3.
The percentage of dose points calculated by the treatment planning system (TPS) with gamma (γ) values less than one when compared with those calculated by Mobius3D (M3D) for VMAT plans for cancers of the prostate, lung, and head and neck
|
||||||
---|---|---|---|---|---|---|
Patient # | Prostate | Lung | Head and Neck | |||
1 | 100 | 99.9 | 99.4 | |||
2 | 99.9 | 98.8 | 99.3 | |||
3 | 100 | 99.8 | 99.3 | |||
4 | 100 | 99.5 | 99.9 | |||
5 | 100 | 100 | 93.2 | |||
6 | 100 | 100 | 99.2 | |||
7 | 100 | 99.8 | 99.1 | |||
8 | 100 | 100 | 99.1 | |||
9 | 100 | 100 | 99.1 | |||
10 | 100 | 99.0 | 99.0 | |||
Average |
|
|
|